加斯德明D调节了结直肠癌中EGFR的激活
Ying Li1, Jiayao Chen2, Huijun Liang1
1Wuxi School of Medicine, Jiangnan University, Wuxi, 214122, China.
Journal of translational medicine
|December 31, 2024
概括
加斯德明D (GSDMD) 通过与EGFR相互作用并激活ERK1/2.2,促进结直肠癌 (CRC) 的进展. 抑制GSDMD为治疗CRC提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 加斯德明D (GSDMD) 是一个关键的热效应因子,但它在结直肠癌 (CRC) 中的作用和全长GSDMD (GSDMD-FL) 的功能仍然不清楚.
- 这项研究调查了GSDMD在CRC的多方面的作用,超出了热灭激活.
研究的目的:
- 阐明GSDMD在结直肠癌进展中的作用.
- 探索GSDMD与CRC中的表皮生长因子受体 (EGFR) 之间的相互作用.
- 评估GSDMD作为CRC的潜在治疗点.
主要方法:
- 在临床CRC样本和细胞系中使用RT-qPCR,西斑和IHC进行GSDMD表达分析.
- 在体外和体外功能测定包括细胞活力,迁移,入侵和瘤异种移植模型.
- 在Gsdmd缺乏的小鼠模型 (AOM-DSS和Apcmin/+) 和RNA测序中分析肠腺瘤的形成.
- 使用CO-IP,西斑和免疫光学,与Gefitinib治疗一起研究GSDMD-EGFR相互作用,以评估EGFR酸化.
主要成果:
- GSDMD在CRC组织和细胞系中高度表达,促进CRC细胞活力,入侵和迁移.
- GSDMD-FL与EGFR相互作用,促进其在Tyr1068的自酸化,并激活下游ERK1/2通路,从而推动CRC的进展.
- 在小鼠中,GSDMD缺乏减少了肠腺瘤的形成,而Gefitinib治疗取消了GSDMD驱动的瘤生成特性.
结论:
- GSDMD-FL通过上调EGFR自酸化和激活ERK1/2通路来促进结直肠癌的进展.
- 向GSDMD为结直肠癌治疗提供了一个有前途的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


